PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $60,912,000 | +250.1% | 1,600,000 | +300.0% | 2.54% | +322.8% |
| Q2 2019 | $17,396,000 | +14.3% | 400,000 | 0.0% | 0.60% | -8.7% |
| Q1 2019 | $15,224,000 | -11.5% | 400,000 | 0.0% | 0.66% | -36.1% |
| Q4 2018 | $17,208,000 | -15.3% | 400,000 | -3.2% | 1.03% | +10.3% |
| Q3 2018 | $20,309,000 | -56.6% | 413,196 | -71.7% | 0.93% | -48.2% |
| Q2 2018 | $46,813,000 | -12.4% | 1,460,610 | -14.8% | 1.80% | -29.4% |
| Q1 2018 | $53,424,000 | +37.9% | 1,715,072 | +102.1% | 2.55% | +1.6% |
| Q4 2017 | $38,737,000 | -21.3% | 848,572 | -35.3% | 2.51% | -34.3% |
| Q3 2017 | $49,245,000 | +121.6% | 1,311,460 | +181.5% | 3.82% | +36.1% |
| Q2 2017 | $22,220,000 | +18.8% | 465,818 | +13.6% | 2.81% | +17.5% |
| Q1 2017 | $18,696,000 | – | 410,000 | – | 2.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |